Nongenomic actions of aldosterone on the renal tubule

Hypertension

Volumn 49, Issue 4, 2007, Pages 728-739

  Good, David W ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; CARRIER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CHANNEL; SODIUM PROTON EXCHANGE PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 3; CELL SURFACE RECEPTOR;

ACID BASE BALANCE; CALCIUM CELL LEVEL; ENZYME PHOSPHORYLATION; HORMONE ACTION; HUMAN; HYPERTENSION; ION TRANSPORT; KIDNEY DISEASE; KIDNEY TUBULE; KIDNEY TUBULE ABSORPTION; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENOME; KIDNEY; METABOLISM; NEPHRON; PHYSIOLOGY;

ALDOSTERONE; ANIMALS; CARRIER PROTEINS; GENOME; HUMANS; ION TRANSPORT; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; NEPHRONS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 34047222286     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000259797.48382.b2     Document Type: Review

References (119)

1. Rossier BC, Palmer LG. Mechanisms of aldosterone action on sodium and potassium transport. In: The Kidney: Physiology and Pathophysiology. Seldin D.W., Giebisch G., eds. New York, NY: Raven Press, Ltd, 1992; 1373-1409.
2. Garty H, Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev. 1997;77:359-396.
3. Alpern RJ. Renal acidification mechanisms. In: The Kidney. Brenner B.M., ed. Philadelphia, PA: Saunders, Vol I, 2000; 455-519.
4. Loffing J, Summa V, Zecevic M, Verrey F. Mediators of aldosterone action in the renal tubule. Curr Opin Nephrol Hypertens. 2001;10:667-675.
5. Bhargava A, Wang J, Pearce D. Regulation of ion transport by aldosterone through changes in gene expression. Mol Cell Endocr. 2004;217:189-196.
6. Vallon V, Lang F. New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure. Curr Opin Nephrol Hypertens. 2005;14:59-66.
7. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556.
8. Vasan RS, Evans JC, Larson MG, Wilson PWF, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
9. Ponda MP, Hostetter TH. Aldosterone antagonism in chronic kidney disease. Clin J Am Soc Nephrol. 2006;1:668-677.
10. Falkenstein E, Tillman H-C, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones- a focus on rapid, nongenomic effects. Pharmacol Rev. 2000;52:513-555.
11. Losel RM, Falkenstein E, Feuring M, Schultz A, Tilman H-C, Rossol-Haseroth K, Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev. 2003;83:965-1016.
12. Funder JW. The nongenomic actions of aldosterone. Endocrine Rev. 2005;26:313-321.
13. Losel R, Schultz A, Boldyreff B, Wehling M. Rapid effects of aldosterone on vascular cells: clinical implications. Steroids. 2004;69:575-578.
14. Mihailidou AS, Funder JW. Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system. Steroids. 2005;70:347-351.
15. Orlowski J, Grinstein S. Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Arch. 2004;447:549-565.
16. + exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol. 2002;42:527-552.
17. Denker SP, Barber DL. Ion transport proteins anchor and regulate the cytoskeleton. Curr Opin Cell Biol. 2002;14:214-220.
18. + exchanger. Nat Genet. 1998;19:282-285.
19. Moe OW. Acute regulation of proximal tubule apical membrane Na/H exchanger NHE3: role of phosphorylation, protein trafficking, and regulatory factors. J Am Soc Nephrol. 1999;10:2412-2425.
20. + exchanger. Am J Physiol Cell Physiol. 2006;290:C757-C763.
21. + exchange and raises cytoplasmic pH in target cells of the amphibian kidney. Proc Natl Acad Sci U S A. 1987;84:1464-1468.
22. + exchange in distal nephron of frog kidney. Pflugers Arch. 1987;408:609-614.
23. + exchange in Madin-Darby canine kidney cells. Pflugers Arch. 1992;422:9-15.
24. 2+ and stimulation of a plasma membrane proton conductance. Proc Natl Acad Sci U S A. 1996;93:10500-10504.
25. Gekle M, Silbernagl S, Wünsch S. Nongenomic action of the mineralocorticoid aldosterone on cytosolic sodium in cultured kidney cells. J Physiol. 1998;511:255-263.
26. + exchange in MDCK cells by aldosterone involves MAP-kinases ERK1/2. Pflugers Arch. 2001;441:781-786.
27. + exchanger isoforms in polarized epithelial cell lines. J Cell Sci. 1996;109:929-939.
28. Harvey BJ, Condliffe S, Doolan CM. Sex and salt hormones: rapid effects in epithelia. News Physiol Sci. 2001;16:174-177.
29. Maguire D, MacNamara B, Cuffe JE, Winter D, Doolan CM, Urbach V, O'Sullivan GC, Harvey BJ. Rapid responses to aldosterone in human distal colon. Steroids. 1999;64:51-63.
30. Winter DC, Schneider MF, O'Sullivan GC, Harvey BJ, Geibel JP. Rapid effects of aldosterone on sodium-hydrogen exchange in isolated colonic crypts. J Membr Biol. 1999;170:17-26.
31. Gekle M, Silbernagl S, Oberleithner H. The mineralocorticoid aldosterone activates a proton conductance in cultured kidney cells. Am J Physiol Cell Physiol. 1997;273:C1673-C1678.
32. Gekle M, Freudinger R, Mildenbergers, Silbernagl S. Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells. Am J Physiol Renal Physiol. 2002;282:F669-F679.
33. + exchanger null mutant mice. Am J Physiol Renal Physiol. 2004;287:F1244-F1249.
34. - absorption through actin cytoskeleton remodeling in renal thick ascending limb. J Biol Chem. 2005;280:11439-11447.
35. - absorption via a nongenomic pathway in medullary thick ascending limb. Am J Physiol Renal Physiol. 2002;283:F699-F706.
36. + exchanger-3 by activation of NHE3 exocytosis. Am J Physiol Renal Physiol. 2005;289:F685-F691.
37. - absorption via a nongenomic ERK-dependent pathway in medullary thick ascending limb. Am J Physiol Renal Physiol. 2006;291:F1005-F1013.
38. +-ATPases in intercalated renal tubule cells by aldosterone. Proc Natl Acad Sci U S A. 2004;101:2636-2641.
39. + channel cell surface expression. EMBO J. 2001;20:7052-7059.
40. Naray-Fejes-Toth A, Helms MN, Stokes JB, Fejes-Toth G. Regulation of sodium transport in mammalian collecting duct cells by aldosterone-induced kinase, SGK1: structure/function studies. Mol Cell Endocrinol. 2004;217:197-202.
41. + channel through convergent phosphorylation of Nedd4-2. J Biol Chem. 2004;279:45753-45758.
42. Zhou Z-H, Bubien JK. Nongenomic regulation of ENaC by aldosterone. Am J Physiol Cell Physiol. 2001;281:1118-1130.
43. + transport. News Physiol Sci. 2000;15:161-165.
44. Schwartz GJ, Burg MB. Mineralocorticoid effects on cation transport by cortical collecting tubules in vitro. Am J Physiol Renal Fluid Electrolyte Physiol. 1978;4:F576-F585.
45. Wingo CS, Kokko JP, Jacobson HR. Effects of in vitro aldosterone on the rabbit cortical collecting tubule. Kidney Int. 1985;28:51-57.
46. Reif MC, Troutman SL, Schafer JA. Sodium transport by rat cortical collecting tubule. Effects of vasopressin and deoxycorticosterone. J Clin Invest. 1986;77:1291-1298.
47. Summa V, Mordasini D, Roger F, Bens M, Martin P-Y, Vandewalle A, Verrey F, Feraille E. Short term effect of aldosterone on Na,K-ATPase cell surface expression in kidney collecting duct cells. J Biol Chem. 2001;276:47087-47093.
48. Fuji Y, Takemoto F, Katz AI. Early effects of aldosterone on Na-K pump in rat cortical collecting tubule. Am J Physiol Renal Fluid Electrolyte Physiol. 1990;259:F40-F45.
49. +-ATPase activity in Madin-Darby Canine Kidney epithelial cells. Am J Physiol Renal Fluid Electrolyte Physiol. 1993;264:F1021-F1026.
50. Eaton DC, Hamilton KL, Johnson KE. Intracellular acidosis blocks the basolateral Na-K pump in rabbit urinary bladder. Am J Physiol. 1984;247:F946-F954.
51. Velazquez H, Bartiss A, Bernstein P, Ellison DH. Adrenal steroids stimulate thiazide-sensitive NaCl transport by rat renal distal tubules. Am J Physiol Renal Fluid Electrolyte Physiol. 1996;270:F211-F219.
52. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci U S A. 1998;95:14552-14557.
53. Wall SM, Knepper MA, Hassell KA, Fischer MP, Shodeinde A, Shin W, Pham TD, Meyer JW, Lorenz JN, Beierwaltes WH, Dietz JR, Shull GE, Kim Y-H. Hypotension in NKCC1 null mice: role of the kidneys. Am J Physiol Renal Physiol. 2006;290:F409-F416.
54. Castrop H, Lorenz JN, Hansen PB, Friis U, Mizel D, Oppermann M, Jensen B, Briggs JP, Skott O, Schnermann J. Contribution of the basolateral isoform of the Na-K-2Cl cotransporter (NKCC1/BSC2) to renin secretion. Am J Physiol Renal Physiol. 2005;289:F1185-F1192.
55. Sheader EA, Wargent ET, Ashton N, Balment RJ. Rapid stimulation of cyclic AMP production by aldosterone in rat inner medullary collecting duct. J Endocrinol. 2002;175:343-347.
56. Koppel H, Christ M, Yard BA, Bar PC, van der Woude FJ, Welling M. Nongenomic effects of aldosterone on human renal cells. J Clin Endocrinol Metab. 2003;88:1297-1302.
57. Tumlin JA, Lea JP, Swanson CE, Smith CL, Edge SS, Someren JS. Aldosterone and dexamethasone stimulate calcineurin activity through a transcription- independent mechanism involving steroid receptor-associated heat shock proteins. J Clin Invest. 1997;99:1217-1223.
58. Braun S, Losel R, Wehling M, Boldyreff B. Aldosterone rapidly activates Src kinase in M-1 cells involving the mineralocorticoid receptor and HSP84. FEBS Lett. 2004;570:69-72.
59. Good DW. The thick ascending limb as a site of renal bicarbonate reabsorption. Semin Nephrol. 1993;13:225-235.
60. Nikola J, Schlingmann KP, Reinalter SC, Komhoff M, Peters M, Waldegger S, Seyberth HW. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Integr Comp Physiol. 2005;288:R782-R795.
61. Rad AK, Balment RJ, Ashton N. Rapid natriuretic action of aldosterone in the rat. J Appl Physiol. 2005;98:423-428.
62. Masilamani S, Knepper MA, Burg MB. Urine concentration and dilution. In: The Kidney. Brenner B.M., ed. Philadelphia, PA: Saunders, Vol I, 2000; 595-635.
63. Le Moellic C, Ouvrard-Pascaud A, Capurro C, Cluzeaud F, Fay M, Jaisser F, Farman N, Blot-Chabaud M. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCα activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. J Am Soc Nephrol. 2004;15:1145-1160.
64. + transport. J Membr Biol. 2001;184:305-311.
65. Rossol-Haseroth K, Zhou Q, Braun S, Boldyreff B, Falkenstein E, Wehling M, Losel RM. Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone. Biochem Biophys Res Comm. 2004;318:281-288.
66. Michlig S, Mercier A, Doucet A, Schild L, Horisberger, J-D, Rossier BC, Firsov D. ERK1/2 controls Na, K-ATPase activity and transepithelial sodium transport in the principal cell of the cortical collecting duct of the mouse kidney. J Biol Chem. 2004;279:51002-51012.
67. Shi H, Asher C, Chigaev A, Yung Y, Reuveny E, Seger R, Garty H. Interactions of β and γENaC with Nedd4 can be facilitated by an ERK-mediated phosphorylation. J Biol Chem. 2002;277:13539-13547.
68. Booth RE, Stockand JD. Targeted degradation of ENaC in response to PKC activation of the ERK1/2 cascade. Am J Physiol Renal Physiol. 2003;284:F938-F947.
69. + reabsorption. Am J Physiol Renal Physiol. 2004;286:F1226-F1231.
70. +-ATPase activity in renal tubule cells. Proc Natl Acad Sci U S A. 1992;89:7394-7397.
71. Lea JP, Sands JM, McMahon SJ, Tumlin JA. Evidence that the inhibition of Na/K-ATPase activity by FK-506 involves calcineurin. Kidney Int. 1994;48:647-652.
72. Krug AW, Papavassiliou F, Hopfer U, Ullrich KJ, Gekle M. Aldosterone stimulates surface expression of NHE3 in renal proximal brush borders. Pflugers Arch Eur J Physiol. 2003;446:492-496.
73. Drumm K, Kress TR, Gassner B, Krug AW, Gekle M. Aldosterone stimulates activity and surface expression of NHE3 in human primary proximal tubule epithelial cells. Cellular Physiol Biochem. 2006;17:21-28.
74. Ganong WF, Mulrow PJ. Rate of change in sodium and potassium excretion after injection of aldosterone into the aorta and renal artery of the dog. Am J Physiol. 1958;195:337-341.
75. Funder JW. Mineralocorticoid receptors: distribution and activation. Heart Failure Rev. 2005;10:15-22.
76. Farman N, Rafestin-Oblin M-E. Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol. 2001;280:F181-F192.
77. Bonvalet JP, Doignon I, Blot-Chabaud M, Pradelles P, Farman N. Distribution of 11β-hydroxysteroid dehydrogenase along the rabbit nephron. J Clin Invest. 1990;86:832-837.
78. Kenouch S, Coutry N, Farman N, Bonvalet JP. Multiple patterns of 11 beta-hydroxysteroid dehydrogenase catalytic activity along the mammalian nephron. Kidney Int. 1992;42:56-60.
79. Krozowski Z, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab. 1995;80:2203-2209.
80. Kyossev Z, Walker PD, Reeves WB. Immunolocalization of NAD-dependent 11β-hydroxysteroid dehydrogenase in human kidney and colon. Kidney Int. 1996;49:271-281.
81. Christ M, Sippell K, Eisen C, Wehling M. Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol Cell Endocrinol. 1994;99:R31-R34.
82. Alzamora R, Michea L, Marusic ET. Role of 11β-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. J Hypertens. 2000;35:1099-1104.
83. Mihailidou AS, Mardini M, Funder JW. Rapid, nongenomic effects of aldosterone in the heart mediated by ε protein kinase C. Endocrinology. 2004;145:773-780.
84. 2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology. 2005;146:973-980.
85. + exchange in vascular smooth muscle cells. J Hypertens. 2005;23:2237-2250.
86. + metabolism. Proc Natl Acad Sci U S A. 1998;95:9424-9429.
87. Bleich M, Warth R, Schmidt-Heiber M, Schulz-Baldes A, Hasselblatt P, Fisch D, Berger S, Kunzelmann K, Kriz W, Schutz G, Greger R. Rescue of the mineralocorticoid receptor knock-out mouse. Pflugers Arch. 1999;438:245-254.
88. Haseroth K, Gerdes D, Berger S, Feuring M, Gunther A, Herbst C, Christ M, Wehling M. Rapid nongenomic effects of aldosterone in mineralocorticoid- receptor-knockout mice. Biochem Biophys Res Commun. 1999;266:257-261.
89. Grossman C, Benesic A, Krug AW, Freudinger R, Mildenberger S, Gassner B, Gekle M. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Molec Endocrinol. 2005;19:1697-1710.
90. Harvey BJ, Doolan CM, Condliffe SB, Renard C, Alzamora R, Urbach V. Non-genomic convergent and divergent signaling of rapid responses to aldosterone and estradiol in mammalian colon. Steroids. 2002;67:483-491.
91. Krug AW, Schuster C, Gassner B, Freudinger R, Mildenberger S, Troppmair J, Gekle M. Human epidermal growth factor receptor-1 expression renders Chinese hamster ovary cells sensitive to alternative aldosterone signaling. J Biol Chem. 2002;277:45892-45897.
92. Filardo EJ. Epidermal growth factor receptor transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Molec Biol. 2002;80:231-238.
93. Schiff R, Massarweh SA, Shou J, Bharwani L, Arpino G, Rimawi M, Osborne CK. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother Pharmacol. 2005;56:s10-s20.
94. Gururaj A, Rayala SK, Vadlamudi RK, Kumar R. Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations. Clin Cancer Res. 2006;12:1001s-1007s.
95. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146:624-632.
96. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625-1630.
97. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B. Nongenomic actions of estrogen and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β. Proc Natl Acad Sci U S A. 2000;97:11603-11608.
98. Ropero AB, Soria B, Nadal A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol. 2002;16:497-505.
99. Srivastava DP, Yu EJ, Kennedy K, Chatwin H, Reale V, Harmon M, Smith T, Evans PD. Rapid, nongenomic responses to ecdysteroids and catecholamines mediated by a novel Drosophila G-protein-coupled receptor. J Neurosci. 2005;25:6145-6155.
100. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci U S A. 2002;99:14783-14788.
101. Manavathi B, Kumar R. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cellular Physiol. 2006;207:594-604.
102. Song R X-D, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. Linking of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol. 2002;16:116-127.
103. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. Proc Natl Acad Sci U S A. 2004;101:17126-17131.
104. Kim KH, Bender JR. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special? Sci STKE. 2005;288:1-4.
105. Vert G, Nemhauser JL, Geldner N, Hong F, Chory J. Molecular mechanisms of steroid hormone signaling in plants. Ann Rev Cell Dev Biol. 2005;21:177-201.
106. Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K, Nagai Y, Nakamura E, Yoshizumi M, Shokoji T, Kimura S, Kiyomoto H, Tsujioka K, Kohno M, Tamaki T, Kajiya F, Abe Y. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension. 2005;45:710-716.
107. Perotti N, He RA, Phillips SA, Haft CR, Taylor SI. Activation of serum-and glucocorticoid-induced protein kinase (Sgk) by cyclic AMP and insulin. J Biol Chem. 2001;276:9406-9412.
108. Mizuno H, Nishida E. The ERK MAP kinase pathway mediates induction of SGK (serum- and glucocorticoid-inducible kinase) by growth factors. Genes Cells. 2001;6:261-268.
109. Gonzalez-Nunez D, Morales-Ruiz M, Levias A, Hebert SC, Poch E. In vitro characterization of aldosterone and cAMP effects in mouse distal convoluted tubule cells. Am J Physiol Renal Physiol. 2004;286:F936-F944.
110. Nielsen J, Kwon T-H, Frokiaer J, Knepper MA, Nielsen S. Maintained ENaC trafficking in aldosterone-infused rats during mineralocorticoid and glucocorticoid receptor blockade. Am J Physiol Renal Physiol. 2007;292:F382-F394.
111. Spindler B, Verey F. Aldosterone action: induction of p21ras and fra-2 and transcription-independent decrease in myc, jun, and fos. Am J Physiol Cell Physiol. 1999;276:C1154-C1161.
112. +-ATPase α1 gene expression through the interaction of aldosterone and cAMP-inducible transcriptional factors. Steroids. 1995;60:147-152.
113. Yasui M, Zelenin SM, Celsi G, Aperia A. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am J Physiol Renal Physiol. 1997;272:F443-F450.
114. 3 action on thick ascending limb via a nongenomic, ERK-dependent pathway. Am J Physiol Cell Physiol. 2003;285:C1122-C1130.
115. Ishaq M, Fan M, Natarajan V. Accumulation of RXR alpha during activation of cycling human T lymphocytes: modulation of RXRE transactivation function by mitogen-activated protein kinase pathways. J Immunol. 2000;165:4217-4225.
116. Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV, Cockwell P, Hewison M, Stewart PM. Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation. 2005;112:1435-1443.
117. Hu X, Li S, McMahon EG, Lala DS, Rudolph AE. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone. Mini Rev Med Chem. 2005;5:709-718.
118. Schmidt BMW, Sammer U, Fleischmann I, Schlaich M, Delles C, Schmeider RE. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension. 2006;47:650-655.
119. Kousteni S, Chen J-R, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002;298:843-846.